HVTN 505 T-cell Immune Correlates of Risk (2017 JID)
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
This dataset contains data through 07 Nov 2014 based on data frozen on 14 Nov 2014.
应用场景：
创建时间：
2025-07-08
相关数据集
Characteristics of HVTN 502 and 503 trial participants.
Data shown are median values (interquartile range) unless otherwise indicated. * At time of sampling § HLA-B*27, B51, B*5701/03, B*5801 and B*8101 Characteristics of HVTN 502 and 503 trial participant
NIAID Data Ecosystem20
Demographic and clinical characteristics of Black participants in HVTN 503.
Demographic and clinical characteristics of Black participants in HVTN 503.
NIAID Data Ecosystem20
An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer
EP2101 is a new cancer vaccine containing 10 different peptide antigens. The vaccine is designed to activate the immune system to develop a response against tumor cells in order to delay or prevent th
NIAID Data Ecosystem20
Dataset from Safety and Immunogenicity Study of GSK Biologicals' Candidate Tuberculosis Vaccine (692342) When Administered to Healthy Infants
This purpose of the study is to assess the safety and immunogenicity of a GSK Biologicals' candidate tuberculosis vaccine (692342) when administered concomitantly with or after the Expanded Programme
NIAID Data Ecosystem20
Dataset from Partially-blind Immunogenicity and Safety Study of GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults.
This study is designed to assess the safety and immunogenicity of a GSK Biologicals' investigational vaccine GSK2321138A in adults 18 years old and older. This study is also designed to assess the lot
NIAID Data Ecosystem20
